Pathophysiological and pharmacotherapeutical aspects of narcolepsy are studied. Blood and cerebrospinal fluid samples of narcoleptic and control patients are evaluated for immunologic and/or genetic factors that may be etiologically significant. Various drug therapies are evaluated objectively and andrenergic and dopaminergic antagonists are evaluated in narcoleptics and control subjects.
Showing the most recent 10 out of 871 publications